Document:

EX-4.3

 Exhibit 4.3 

FIRST AMENDMENT 
 TO

 FOURTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

This FIRST AMENDMENT TO FOURTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Amendment”)
is made and entered into as of October 17, 2018, by and among Axonics Modulation Technologies, Inc., a Delaware corporation (the “Company”), and the persons and entities signatory hereto (collectively, the
“Investors”), and amends that certain Fourth Amended and Restated Investors’ Rights Agreement, dated as of March 29, 2018, by and among the Company and the persons and entities signatory thereto (the “Rights
Agreement”). Capitalized terms not defined herein shall have the meanings given to such terms in the Rights Agreement. 

RECITALS 
 WHEREAS, the
Company and the Investors desire to amend the Rights Agreement pursuant to Section 4.7 thereof to provide for (i) a modification to the definition of a “Qualified Offering” set forth in Section 1.10 thereof and (ii) the
termination of the covenants set forth in Section 3.5 thereof upon the closing of a Qualified Offering; 
 WHEREAS, pursuant to
Section 4.7 of the Rights Agreement, the Rights Agreement may be modified, amended, or waived only with the written consent of the Company and the Holders of at least 66-2/3% of the Registrable
Securities; and 
 WHEREAS, the Investors represent Holders of at least 66-2/3% of the Registrable
Securities, constituting the requisite threshold for the amendment of the Rights Agreement. 
 AGREEMENT 

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged and agreed, the parties
hereby agree as follows: 
 1. Amendment to Section 1.10. Section 3.5 of the Rights Agreement is hereby
amended and restated in its entirety to read as follows: 
 “1.10 Qualified Offering” shall mean the Company’s
first firm commitment underwritten public offering of its Common Stock under the Securities Act with aggregate gross proceeds of at least $50,000,000 (before deduction of underwriters commissions and expenses) and a per share price equal to at least
$12.00.” 
 2. Amendment of Section 3.5. Section 3.5 of the Rights Agreement is
hereby amended to add the following sentence to the end of Section 3.5: 
 “This
Section 3.5 shall terminate and be of no further force or effect upon (i) the closing of a Qualified Offering, or (ii) a Liquidation, whichever event shall first occur.” 

3. Governing Law. This Amendment shall be governed, construed and enforced in accordance with the laws of the State of
California without giving effect to the principles of conflicts of law thereof. 

 4. Amendment and Ratification. The parties agree that the Rights Agreement is
hereby amended in accordance with this Amendment. Except as specifically amended hereby, all terms, conditions, covenants, representations and warranties contained in the Rights Agreement shall remain in full force and effect, and shall be binding
upon each holder of any securities purchased under the Rights Agreement. 
 5. Counterparts. This Amendment may be executed in
any number of counterparts, each of which shall be deemed an original, but all of which together shall constitute but one and the same instrument. This Amendment may be executed on signature pages exchanged by facsimile or electronic mail, which
copies shall be equally as effective as delivery of an original executed counterpart of this Amendment. 
 [Remainder of page
intentionally left blank] 

  
 2 

 IN WITNESS WHEREOF, the parties hereto have caused this First Amendment to Fourth Amended
and Restated Investors’ Rights Agreement to be executed as of the date first above written. 
  

	
	COMPANY:
	
	 AXONICS MODULATION TECHNOLOGIES, INC.

	
	 By:  /s/ Raymond W. Cohen

	 Name:  Raymond W. Cohen

	Title:  CEO                                  
                                         
     

  
 Signature Page to First
Amendment to Fourth Amended and Restated Investors’ Rights Agreement 

 IN WITNESS WHEREOF, the parties hereto have caused this First Amendment to Fourth Amended
and Restated Investors’ Rights Agreement to be executed as of the date first above written. 
  

	
	INVESTOR:
	
	BIODISCOVERY 4 FCPR
	
	By: Andera Partners
	Its: Manager
	
	 By:  /s/ Raphaël Wisniewski

	 Name:  Raphaël Wisniewski

	Title:  Partner                                  
                                      

  
 Signature Page to First
Amendment to Fourth Amended and Restated Investors’ Rights Agreement 

 IN WITNESS WHEREOF, the parties hereto have caused this First Amendment to Fourth Amended
and Restated Investors’ Rights Agreement to be executed as of the date first above written. 
  

									
	INVESTOR:
	
	NEOMED INNOVATION V, L.P.
		
	By:	 	NeoMed Innovation V Limited
	Its:	 	General Partner
			
	By:	 	/s/ Ashley Vardon	 	/s/ Christina Kembery
	Name: Ashley Vardon	 		 	Christina Kembery
	Title: Director	 		 	Director

  
 Signature Page to First
Amendment to Fourth Amended and Restated Investors’ Rights Agreement 

 IN WITNESS WHEREOF, the parties hereto have caused this First Amendment to Fourth Amended
and Restated Investors’ Rights Agreement to be executed as of the date first above written. 
  

	
	INVESTOR:
	
	THE ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH
	
	 By: /s/ John G. Petrovich

	
	 Name: John G. Petrovich

	
	Title: President and CEO

  
 Signature Page to First
Amendment to Fourth Amended and Restated Investors’ Rights Agreement 

 IN WITNESS WHEREOF, the parties hereto have caused this First Amendment to Fourth Amended
and Restated Investors’ Rights Agreement to be executed as of the date first above written. 
  

	
	INVESTOR:
	
	ADVENT LIFE SCIENCES LLP
	
	
By:  /s/ Shahzad Malik            
                                    

	
	 Name:  Shahzad Malik

	
	Title:  

  
 Signature Page to First
Amendment to Fourth Amended and Restated Investors’ Rights Agreement 

 IN WITNESS WHEREOF, the parties hereto have caused this First Amendment to Fourth Amended
and Restated Investors’ Rights Agreement to be executed as of the date first above written. 
  

	
	INVESTOR:
	
	ADVENT LIFE SCIENCES FUND II LP
	
	By: Advent Life Sciences LLP
	Its: General Partner
	
	By:  /s/ Shahzad Malik                               
                         
	
	 Name:  Shahzad Malik

	
	Title:  General Partner

  
 Signature Page to First
Amendment to Fourth Amended and Restated Investors’ Rights Agreement 

 IN WITNESS WHEREOF, the parties hereto have caused this First Amendment to Fourth Amended
and Restated Investors’ Rights Agreement to be executed as of the date first above written. 
  

	
	INVESTOR:
	
	COÖPERATIEVE GILDE HEALTHCARE IV U.A.
	
	
By:   /s/ Marc Olivier Perret        
/s/ Pieter van der Meer   

	
	
Name:  Marc Olivier Perret           
   Pieter van der Meer

	
	Title:  Managing Partner                   Managing Partner

  
 Signature Page to First
Amendment to Fourth Amended and Restated Investors’ Rights Agreement 

 IN WITNESS WHEREOF, the parties hereto have caused this First Amendment to Fourth Amended
and Restated Investors’ Rights Agreement to be executed as of the date first above written. 
  

	
	INVESTOR:
	
	LONGITUDE VENTURE PARTNERS III, L.P.
	
	By: Longitude Capital Partners III, LLC
	Its: General Partner
	
	
By:      /s/ Juliet Tammenoms Bakker     
                      

	
	 Name:  Juliet Tammenoms Bakker

	
	Title:  Managing Director

  
 Signature Page to First
Amendment to Fourth Amended and Restated Investors’ Rights AgreementEX-10.8

 Exhibit 10.8 

AXONICS MODULATION TECHNOLOGIES, INC. 

2018 OMNIBUS INCENTIVE PLAN 

Axonics Modulation Technologies, Inc. sets forth herein the terms of its 2018 Omnibus Incentive Plan. 

 

	1.	 PURPOSE 

The Plan is intended to enhance Axonics and its Affiliates ability to attract, retain and motivate employees, consultants, and non-employee directors, by providing to such persons an opportunity to acquire or increase a direct proprietary interest in the Company. To this end, the Plan provides for the grant of stock options (nonstatutory
and incentive), stock appreciation rights, restricted shares, restricted stock units, other stock-based awards, and cash awards. Upon becoming effective, the Plan replaces, and no further awards may be made under, the Prior Plan, provided
that outstanding awards under the Prior Plan will continue to remain subject to the terms of the Prior Plan. 
  

	2.	 DEFINITIONS 

For purposes of interpreting the Plan and related documents (including Award Agreements), the following definitions shall apply: 

“Affiliate” means any company or other trade or business that “controls,” is “controlled by,” or is “under common
control with,” the Company within the meaning of Rule 405 of Regulation C under the Securities Act, including any Subsidiary. 

“Award” means a grant, under the Plan, of (1) an Option, (2) a Stock Appreciation Right, (3) Restricted Shares,
(4) Restricted Stock Units, (5) an Other Stock-based Award, (6) a cash award, or (7) a Substitute Award. 
 “Award
Agreement” means a written agreement between the Company and a Grantee, or notice from the Company or an Affiliate to a Grantee that evidences and sets out the terms of an Award. 

“Beneficial Owner” shall have the meaning assigned to such term in Rule 13d-3 and Rule 13d-5 under the Exchange Act, except that in calculating the beneficial ownership of any particular Person, that Person shall be deemed to have beneficial ownership of all securities that the Person has the right to
acquire by conversion or exercise of other securities, whether such right is currently exercisable or is exercisable only after the passage of time. The terms “Beneficially Owns” and “Beneficially Owned” have corresponding
meanings. 
 “Board” means the Board of Directors of the Company. 

“Business Combination” means the consummation of a reorganization, merger, consolidation, or sale or other disposition of all or
substantially all of the assets of the Company. 
 “Cause” shall be defined as that term is defined in the Grantee’s offer letter or
other applicable employment agreement; or, if there is no such definition, “Cause” means, as determined by the Company and unless otherwise provided in the applicable Award Agreement: (1) the commission of any act by the Grantee
constituting financial dishonesty against the Company or its Affiliates; (2) the Grantee’s engaging in any other act of dishonesty, fraud, intentional misrepresentation, moral turpitude, illegality, or harassment that would
(A) adversely affect the business or the reputation of the Company or any of its Affiliates with their respective current or prospective customers, suppliers, lenders, or other third parties with whom such entity does or might do business or
(B) expose the Company or any of its Affiliates to a risk of civil or criminal legal damages, liabilities, or penalties; (3) the repeated failure by the Grantee to follow the directives of the chief executive officer of the

  
 1 

 
Company or any of its Affiliates or the Board; or (4) any material misconduct, violation of Company or Affiliate policy, or willful and deliberate
non-performance of duty by the Grantee in connection with the business affairs of the Company or its Affiliates. A Separation from Service for Cause may also include a determination by the Company after the
Grantee’s Separation from Service that circumstances existing before the Separation from Service would have entitled the Company or an Affiliate to have terminated the Grantee’s service for Cause. All rights a Grantee has or may have under
the Plan shall be suspended automatically during the pendency of any investigation by the Company, or during any negotiations between the Company and the Grantee, regarding any actual or alleged act or omission by the Grantee of the type described
in the applicable definition of Cause. 
 “Change in Control” means, except as otherwise provided by the Board, the occurrence of any of
the following events: 
  

	(1)	 The acquisition by any Person of Beneficial Ownership of 50% or more of the outstanding voting power;
provided, however, that the following acquisitions shall not constitute a Change in Control for purposes of this subparagraph (1): (A) any acquisition directly from the Company; (B) any acquisition by the Company or any of its
Affiliates; (C) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or any of its Affiliates; or (D) any acquisition by any corporation under a transaction that complies with clauses (A),
(B), and (C) of subparagraph (3) below; or 

  

	(2)	 Individuals who at the beginning of any one-year period constitute the
Board (the “Incumbent Board”) cease for any reason to constitute at least a majority of the Board; provided, however, that any individual who becomes a director of the Company during such
one-year period and whose election, or whose nomination for election by the Stockholders, to the Board was either (A) approved by a vote of at least a majority of the directors then comprising the
Incumbent Board or (B) recommended by a nominating committee comprised entirely of directors who are then Incumbent Board members shall be considered as though such individual were a member of the Incumbent Board, but excluding, for this
purpose, any such individual whose initial assumption of office occurs as a result of either an actual or threatened election contest (as such terms are used in Rule 14a-11 of Regulation 14A promulgated under
the Exchange Act), other actual or threatened solicitation of proxies or consents or an actual or threatened tender offer; or 

  

	(3)	 A Business Combination, unless after the Business Combination: (A) all or substantially all of the Persons
who were the Beneficial Owners, respectively, of the outstanding shares and outstanding voting securities immediately before the Business Combination own, directly or indirectly, more than 50% of the combined voting power of the then outstanding
voting securities entitled to vote generally in the election of directors of the Company, as the case may be, of the entity resulting from the Business Combination (including an entity that as a result of such transaction owns the Company or all or
substantially all of the Company’s assets either directly or through one or more subsidiaries) in substantially the same proportions as their ownership, immediately before such Business Combination, of the outstanding voting securities
(provided, however, that for purposes of this clause (A) any shares of common stock or voting securities of such resulting entity received by such Beneficial Owners in such Business Combination other than as the result of such
Beneficial Owners’ ownership of outstanding shares or outstanding voting securities immediately before such Business Combination shall not be considered to be owned by such Beneficial Owners for the purposes of calculating their percentage of
ownership of the outstanding common stock and voting power of the resulting entity); (B) no Person (excluding any entity resulting from such Business Combination or any employee benefit plan (or related trust) of the Company or such entity
resulting from the Business Combination) becomes the Beneficial Owner, directly or indirectly, of 50% or more of the combined voting power of the then outstanding voting securities of such entity resulting from the Business Combination unless such
Person owned 50% or more of the outstanding shares or outstanding voting securities immediately before the Business Combination; and (C) at least a majority of the members of the Board of the entity resulting from such Business Combination were
members of the Incumbent Board at the time of the execution of the initial agreement, or the action of the Board, providing for such Business Combination; or 

  
 2 

	(4)	 Approval by the Stockholders of a complete liquidation or dissolution of the Company. 

Solely to the extent required by Section 409A, an event described above shall not constitute a Change in Control for purposes of the
payment (but not vesting) terms of any Award subject to Section 409A unless such event also constitutes a change in ownership or effective control of the Company or a change in the ownership of a substantial portion of the Company’s assets
within the meaning of Section 409A. 
 “Code” means the Internal Revenue Code of 1986. 

“Committee” means any committee or other person or persons designated by the Board to administer the Plan. The Board shall cause the
Committee to satisfy all applicable laws and the applicable requirements of any securities exchange on which the Common Stock may then be listed. All references in the Plan to the Board shall mean such Committee or the Board. 

“Company” means Axonics Modulation Technologies, Inc., a Delaware corporation. 

“Common Stock” means the common stock of the Company. 

“Consultant” means any person, except an employee or Non-Employee Director, engaged by the Company or
any Affiliate, to render personal services to such entity, including as an advisor. 
 “Corporate Transaction” means a reorganization,
merger, statutory share exchange, consolidation, sale of all or substantially all of the Company’s assets, or the acquisition of assets or stock of another entity by the Company, or other corporate transaction involving the Company or any of
its Affiliates. 
 “Detrimental Conduct” means, as determined by the Company, the Grantee’s serious misconduct or unethical behavior,
including any of the following: (1) any violation by the Grantee of a restrictive covenant agreement that the Grantee has entered into with the Company or an Affiliate (covering, for example, confidentiality,
non-competition, non-solicitation, non-disparagement, etc.); (2) any conduct by the Grantee that could result in the
Grantee’s Separation from Service for Cause; (3) the commission of a criminal act by the Grantee; (4) the Grantee’s breach of a fiduciary duty owed to the Company; (5) the Grantee’s intentional violation, or grossly
negligent disregard, of the Company’s policies, rules, or procedures; or (6) the Grantee taking or maintaining trading positions that result in a need to restate financial results in a subsequent reporting period or that result in a
significant financial loss to the Company. 
 “Disability” shall be defined as that term is defined in the Grantee’s offer letter or
other applicable employment agreement; or, if there is no such definition, “Disability” means, as determined by the Company and unless otherwise provided in the applicable Award Agreement, the Grantee is unable to perform each of the
essential duties of the Grantee’s position by reason of a medically determinable physical or mental impairment that is potentially permanent in character or that can be expected to last for a continuous period of not less than 12 months;
provided, however, that, with respect to rules regarding expiration of an Incentive Stock Option after termination of the Grantee’s employment, “Disability” means “permanent and total disability” as set forth
in Code Section 22(e)(3). 
 “Effective Date” means October 18, 2018. 

“Exchange Act” means the Securities Exchange Act of 1934. 

  
 3 

 “Fair Market Value” of a Share as of a particular date means (1) if the Shares are
listed on a national securities exchange, the closing price of a Share as quoted on such exchange or other comparable reporting system for the first regular trading day immediately preceding the applicable date; or (2) if the Shares are not
then listed on a national securities exchange, the closing price of a Share quoted by an established quotation service for over-the-counter securities for the first
trading day immediately preceding the applicable date; or (3) if the Shares are not then listed on a national securities exchange or quoted by an established quotation service for
over-the-counter securities, or the value of the Shares is not otherwise determinable, such value as determined by the Board. Notwithstanding the foregoing, if the Board
determines that an alternative definition of Fair Market Value should be used in connection with the grant, exercise, vesting, settlement, or payout of any Award, it may specify such alternative definition in the applicable Award Agreement. Such
alternative definition may include a price that is based on the opening, actual, high, low, or average selling prices of a Share on the applicable securities exchange on the given date, the trading date preceding the given date, the trading date
next succeeding the given date, or an average of trading days. 
 “GAAP” means U.S. Generally Accepted Accounting Principles. 

“Grant Date” means the latest to occur of (1) the date as of which the Board approves an Award, (2) the date on which the recipient
of an Award first becomes eligible to receive an Award under Section 6, or (3) such other date as may be specified by the Board in the Award Agreement. 

“Grantee” means a person who receives or holds an Award. 

“Incentive Stock Option” means an Option that is an “incentive stock option” within the meaning of Code Section 422. 

“IPO” means the initial public offering of Shares pursuant to a registration statement (other than a Form
S-8) filed with, and declared effective by, the SEC. 
 “Issued Share” means an outstanding Share
issued under an Award (including a Restricted Share). 
 “Non-Employee Director” means a member of
the Board who is not an employee. 
 “Nonstatutory Stock Option” means an Option that is not an Incentive Stock Option. 

“Option” means an option to purchase one or more Shares under the Plan. 

“Option Price” means the exercise price for each Share subject to an Option. 

“Other Stock-based Award” means an Award consisting of Share units, or other Awards, valued in whole or in part by reference to, or otherwise
based on, Common Stock, other than Options, SARs, Restricted Shares, and RSUs. 
 “Performance Award” means an Award made subject to the
attainment of performance goals over a performance period established by the Board. 
 “Person” means a person as defined in
Section 13(d)(3) of the Exchange Act. 
 “Plan” means this Axonics Modulation Technologies, Inc. 2018 Omnibus Incentive Plan. 

“Prior Plan” means the Company’s 2014 Stock Incentive Plan. 

“Purchase Price” means the purchase price for each Share under a grant of Restricted Shares. 

  
 4 

 “Restricted Period” shall have the meaning set forth in
Section 10.1. 
 “Restricted Shares” means restricted Shares awarded to a Grantee under
Section 10. 
 “Restricted Stock Unit” or “RSU” means a right to receive one Share, awarded to a
Grantee under Section 10. 
 “SAR Exercise Price” means the per Share exercise price of a SAR granted under
Section 9. 
 “SEC” means the U.S. Securities and Exchange Commission. 

“Section 409A” means Code Section 409A. 

“Securities Act” means the Securities Act of 1933, as amended. 

“Separation from Service” means the termination of the applicable Grantee’s employment with, and performance of services for, the
Company and each Affiliate. Unless otherwise determined by the Company, if a Grantee’s employment or service with the Company or an Affiliate terminates but the Grantee continues to provide services to the Company or an Affiliate in a non-employee director capacity or as an employee, officer, or consultant, as applicable, such change in status shall not be deemed a Separation from Service. Approved temporary absences from employment because of
illness, vacation, or leave of absence and transfers among the Company and its Affiliates shall not be considered Separations from Service. Notwithstanding the foregoing, with respect to any Award that constitutes nonqualified deferred compensation
under Section 409A, “Separation from Service” shall mean a “separation from service” as defined under Section 409A. 

“Service Provider” means an employee, officer, Non-Employee Director, or Consultant of the Company or
an Affiliate. 
 “Share” means one share of Common Stock. 

“Stock Appreciation Right” or “SAR” means a right granted to a Grantee under Section 9. 

“Stockholder” means a stockholder of the Company. 

“Subsidiary” means any corporation, partnership, joint venture, affiliate, or other entity in which the Company owns more than 50% of the
voting stock or voting ownership interest, as applicable, or any other business entity designated by the Board as a Subsidiary for purposes of the Plan. 

“Substitute Award” means any Award granted in assumption of or in substitution for an award of a company or business acquired by the Company
or an Affiliate or with which the Company or an Affiliate combines. 
 “Ten Percent Stockholder” means an individual who owns more than 10%
of the total combined voting power of all classes of outstanding stock of the Company, its parent, or any of its Subsidiaries. In determining stock ownership, the attribution rules of Code Section 424(d) shall be applied. 

“Termination Date” means the date that is 10 years after the Effective Date, unless the Plan is earlier terminated by the Board under
Section 5.2. 

  
 5 

	3.	 ADMINISTRATION OF THE PLAN 

 

	 	3.1.	 General 

Except as specifically provided in Section 14 or as otherwise may be required by applicable law, regulatory
requirement, or the certificate of incorporation or the bylaws of the Company, the Board shall have full power and authority to take all actions and to make all determinations required or provided for under the Plan, any Award or any Award
Agreement, and shall have full power and authority to take all such other actions and make all such other determinations that the Board deems to be necessary or appropriate to the administration of the Plan. The interpretation and construction by
the Board of the Plan, any Award, or any Award Agreement shall be final, binding, and conclusive. Without limitation, the Board shall have full and final authority, subject to the other terms of the Plan, to: 

 

	 	(1)	 designate Grantees; 

  

	 	(2)	 determine the type or types of Awards to be made to a Grantee; 

 

	 	(3)	 determine the number of Shares to be subject to an Award; 

 

	 	(4)	 establish the terms of each Award (including the Option Price of any Option, the nature and duration of any
restriction or condition (or provision for lapse thereof) relating to the vesting, exercise, transfer, or forfeiture of an Award or the Shares subject thereto, and any terms that may be necessary to qualify Options as Incentive Stock Options);

  

	 	(5)	 prescribe the form of each Award Agreement; and 

 

	 	(6)	 amend, modify, or supplement the terms of any outstanding Award, including the authority, in order to
effectuate the purposes of the Plan, to modify Awards to foreign nationals or individuals who are employed outside the U.S. to recognize differences in local law, tax policy, or custom. 

To the extent permitted by applicable law, the Board shall have full power and authority to delegate its administrative powers and
responsibilities under the Plan to the Committee, which shall have full authority to act in accordance with any applicable charter, and with respect to the authority of the Board to act hereunder, all references to the Board shall be deemed to
include a reference to the Committee, to the extent such power or responsibilities have been delegated. Any such delegate shall serve at the pleasure of and may be removed at any time by the Board. The Board shall retain the right to exercise any
authority delegated to the Committee to the extent consistent with applicable law and the applicable requirements of any securities exchange on which the Common Stock may then be listed. 

 

	 	3.2.	 No Repricing 

This Section 3.2 shall be applicable only after an IPO. Notwithstanding any other term of the Plan, the repricing of
Options or SARs is prohibited without prior approval of the Stockholders. For this purpose, a “repricing” means any of the following (or any other action that has the same effect as any of the following): (1) changing an Option or SAR to
lower its Option Price or SAR Exercise Price; (2) any other action that is treated as a “repricing” under GAAP; and (3) repurchasing for cash or canceling an Option or SAR at a time when its Option Price or SAR Exercise Price is
greater than the Fair Market Value of the underlying Shares in exchange for another Award, unless the actions contemplated in clauses (1), (2), or (3) occur in connection with a change in capitalization or similar change under
Section 15. A cancellation and exchange under clause (3) would be considered a “repricing” regardless of whether it is treated as a “repricing” under GAAP and regardless of whether it is voluntary
on the part of the Grantee. 

  
 6 

	 	3.3.	 Separation from Service for Cause; Clawbacks; Detrimental Conduct 

 

	 	3.3.1.	 Separation from Service for Cause 

The Company may annul an Award if the Grantee incurs a Separation from Service for Cause. 

 

	 	3.3.2.	 Detrimental Conduct 

Except as otherwise provided by the Board, notwithstanding any other term of the Plan, if a Grantee engages in Detrimental
Conduct, whether during the Grantee’s service or after the Grantee’s Separation from Service, in addition to any other penalties or restrictions that may apply under the Plan, state law, or otherwise, the Grantee shall forfeit or pay to
the Company the following: 
  

	 	(1)	 any and all outstanding Awards granted to the Grantee, including Awards that have become vested or exercisable;

  

	 	(2)	 any cash or Shares received by the Grantee in connection with the Plan within a
12-month month period immediately before the date the Company determines the Grantee has engaged in Detrimental Conduct; and 

 

	 	(3)	 the profit realized by the Grantee from the sale, or other disposition for consideration, of any Shares
received by the Grantee in connection with the Plan within a 12-month period immediately before the date the Company determines the Grantee has engaged in Detrimental Conduct. 

 

	 	3.4.	 Deferral Arrangement 

The Board may permit or require the deferral of any Award payment into a deferred compensation arrangement, subject to such rules and
procedures as it may establish and in accordance with Section 409A, which may include terms for the payment or crediting of interest or dividend equivalents, including converting such credits into deferred units. 

 

	 	3.5.	 No Liability 

No member of the Board shall be liable for any action or determination made in good faith with respect to the Plan, any Award, or Award
Agreement. 
  

	 	3.6.	 Book Entry 

Notwithstanding any other term of the Plan, the Company may elect to satisfy any requirement under the Plan for the delivery of stock
certificates through the use of book entry. 
  

	4.	 SHARES SUBJECT TO THE PLAN 

 

	 	4.1.	 Authorized Number of Shares 

Subject to adjustment under Section 15, the total number of Shares authorized to be awarded under the Plan shall not
exceed the sum of (1) 4,500,000 and (2) the number of Shares available for the grant of awards as of the Effective Date under the Prior Plan. In addition, Shares underlying any outstanding award granted under the Prior Plan that, after the
Effective Date, expires, or is terminated, surrendered, or forfeited for any reason without issuance of Shares shall be available for the grant of new Awards. As provided in Section 1, no new awards shall

  
 7 

 
be granted under the Prior Plan after the Effective Date. Shares issued under the Plan shall consist in whole or in part of authorized but unissued Shares, treasury Shares, or Shares purchased on
the open market or otherwise, all as determined by the Company from time to time. 
  

	 	4.2.	 Share Counting 

 

	 	4.2.1.	 General 

Each Share granted in connection with an Award shall be counted as one Share against the limit in
Section 4.1, subject to this Section 4.2. Share-based Performance Awards shall be counted assuming maximum performance results (if applicable) until such time as actual performance results can be
determined. 
  

	 	4.2.2.	 Cash-Settled Awards 

Any Award settled in cash shall not be counted as Shares for any purpose under the Plan. 

 

	 	4.2.3.	 Expired or Terminated Awards 

If any Award expires, or is terminated, surrendered, or forfeited, in whole or in part, the unissued Shares covered by that
Award shall again be available for the grant of Awards. 
  

	 	4.2.4.	 Repurchased, Surrendered, or Forfeited Awards 

If Issued Shares are repurchased, surrendered or forfeited to the Company at no more than cost, such Shares shall again be
available for the grant of Awards. 
  

	 	4.2.5.	 Payment of Option Price or Tax Withholding in Shares 

If Shares issuable upon exercise, vesting, or settlement of an Award, or Shares owned by a Grantee (that are not subject to any
pledge or other security interest), are surrendered or tendered to the Company in payment of the Option Price or Purchase Price of an Award or any taxes required to be withheld in respect of an Award, in each case, in accordance with the terms of
the Plan, such surrendered or tendered Shares shall again be available for the grant of Awards. 
  

	 	4.2.6.	 Substitute Awards 

In the case of any Substitute Award, such Substitute Award shall not be counted against the number of Shares reserved under the
Plan. 
  

	 	4.3.	 Award Limits 

  

	 	4.3.1.	 Incentive Stock Options 

Subject to adjustment under Section 15 and notwithstanding Section 4.1, the
maximum number of Shares available for issuance under Incentive Stock Options under the Plan shall be 4,500,000. 

  
 8 

	5.	 EFFECTIVE DATE, DURATION, AND AMENDMENTS 

 

	 	5.1.	 Term 

The Plan shall be effective as of the Effective Date. The Plan shall terminate automatically on the
10-year anniversary of the Effective Date and may be terminated on any earlier date as provided in Section 5.2. 

 

	 	5.2.	 Amendment and Termination of the Plan 

The Board may, at any time and from time to time, amend, suspend, or terminate the Plan as to any Awards that have not been made. An amendment
shall be contingent on approval of the Stockholders to the extent stated by the Board, required by applicable law, or required by applicable securities exchange listing requirements. Notwithstanding the foregoing, after an IPO, any amendment to
Section 3.2 shall be contingent upon the approval of the Stockholders. No Awards may be granted after the Termination Date. The applicable terms of the Plan and any terms applicable to Awards granted before the Termination
Date shall survive the termination of the Plan and continue to apply to such Awards. No amendment, suspension, or termination of the Plan shall, without the consent of the Grantee, materially impair rights or obligations under any Award theretofore
awarded. 
  

	6.	 AWARD ELIGIBILITY AND LIMITATIONS 

 

	 	6.1.	 Service Providers 

Subject to this Section 6.1, Awards may be made to any Service Provider as the Board may determine and designate from
time to time. 
  

	 	6.2.	 Successive Awards 

An eligible person may receive more than one Award, subject to such restrictions as are provided herein. 

 

	 	6.3.	 Stand-Alone, Additional, Tandem, and Substitute Awards 

The Board may grant Awards either alone or in addition to, in tandem with, or in substitution or exchange for, any other Award or any award
granted under another plan of the Company, any Affiliate, or any business entity to be acquired by the Company or an Affiliate, or any other right of a Grantee to receive payment from the Company or any Affiliate. Such additional, tandem, and
substitute or exchange Awards may be granted at any time. If an Award is granted in substitution or exchange for another Award, the Board shall have the right to require the surrender of such other Award in consideration for the grant of the new
Award. Subject to Section 3.2, the Board shall have the right to make Awards in substitution or exchange for any other award under another plan of the Company, any Affiliate, or any business entity to be acquired by the
Company or an Affiliate. In addition, Awards may be granted in lieu of cash compensation, including in lieu of cash amounts payable under other plans of the Company or any Affiliate, in which the value of Shares subject to the Award is equivalent in
value to the cash compensation (for example, RSUs or Restricted Shares). 
  

	7.	 AWARD AGREEMENT 

Each Award shall be evidenced by an Award Agreement, in such form or forms as the Board shall from time to time determine. Without limiting the
foregoing, an Award Agreement may be provided in the form of a notice that provides that acceptance of the Award constitutes acceptance of all terms of the Plan and the notice. Award Agreements granted from time to time or at the same time need not
contain similar terms but shall be consistent with the terms of the Plan. Each Award Agreement evidencing an Award of Options shall specify whether such Options are intended to be Nonstatutory Stock Options or Incentive Stock Options, and in the
absence of such specification such options shall be deemed Nonstatutory Stock Options. 

  
 9 

	8.	 TERMS OF OPTIONS 

 

	 	8.1.	 Option Price 

The Option Price of each Option shall be fixed by the Board and stated in the related Award Agreement. The Option Price of each Option (except
those that constitute Substitute Awards) shall be at least the Fair Market Value of a Share on the Grant Date; provided, however, that in the event that a Grantee is a Ten Percent Stockholder as of the Grant Date, the Option Price of
an Option granted to such Grantee that is intended to be an Incentive Stock Option shall be not less than 110% of the Fair Market Value of a Share on the Grant Date. In no case shall the Option Price of any Option be less than the par value of a
Share. 
  

	 	8.2.	 Vesting 

Subject to Section 8.3, each Option shall become exercisable at such times and under such terms (including
performance requirements) as may be determined by the Board and stated in the Award Agreement. 
  

	 	8.3.	 Term 

Each Option shall terminate, and all rights to purchase Shares thereunder shall cease, upon the expiration of a period not to exceed 10
years from the Grant Date, or under such circumstances and on any date before 10 years from the Grant Date as may be set forth in the Plan or as may be fixed by the Board and stated in the related Award Agreement; provided,
however, that in the event that the Grantee is a Ten Percent Stockholder, an Option granted to such Grantee that is intended to be an Incentive Stock Option at the Grant Date shall not be exercisable after the expiration of five years from
its Grant Date. 
  

	 	8.4.	 Limitations on Exercise of Option 

Notwithstanding any other term of the Plan, in no event may any Option be exercised, in whole or in part, after the occurrence of an event that
results in termination of the Option. 
  

	 	8.5.	 Method of Exercise 

An Option that is exercisable may be exercised by the Grantee’s delivery of a notice of exercise to the Company, setting forth the number
of Shares with respect to which the Option is to be exercised, accompanied by full payment for the Shares. To be effective, notice of exercise must be made in accordance with procedures established by the Company from time to time. 

 

	 	8.6.	 Rights of Holders of Options 

Unless otherwise stated in the related Award Agreement, an individual holding or exercising an Option shall have none of the rights of a
Stockholder (for example, the right to receive cash or dividend payments or distributions attributable to the subject Shares or to direct the voting of the subject Shares) until the Shares covered thereby are fully paid and issued to him. Except as
provided in Section 15 or the related Award Agreement, no adjustment shall be made for dividends, distributions, or other rights for which the record date is before the date of such issuance. 

  
 10 

	 	8.7.	 Limitations on Incentive Stock Options 

An Option shall constitute an Incentive Stock Option only (1) if the Grantee of the Option is an employee of the Company or any
Subsidiary; (2) to the extent specifically provided in the related Award Agreement; and (3) to the extent that the aggregate Fair Market Value (determined at the time the Option is granted) of the Shares with respect to which all Incentive
Stock Options held by such Grantee become exercisable for the first time during any calendar year (under the Plan and all other plans of the Grantee’s employer and its Affiliates) does not exceed $100,000. This limitation shall be applied by
taking Options into account in the order in which they were granted. No Option shall be treated as an Incentive Stock Option unless the Plan has been approved by the Stockholders in a manner intended to comply with the stockholder approval
requirements of Code Section 422, provided that any Option intended to be an Incentive Stock Option shall not fail to be effective solely on account of a failure to obtain such approval, but rather such Option shall be treated as a
Nonstatutory Stock Option unless and until such approval is obtained. 
  

	 	8.8.	 Early Exercise 

An Option may include a term that allows the Grantee to elect at any time before the Grantee’s Separation from Service to exercise the
Option as to any part or all of the Shares subject to the Option prior to the full vesting of the Option. Any unvested Shares so purchased shall be subject to a repurchase option in favor of the Company and to any other restrictions the Board
determines to be appropriate. 
  

	9.	 TERMS OF STOCK APPRECIATION RIGHTS (SARs) 

 

	 	9.1.	 Right to Payment 

A SAR shall confer on the Grantee a right to receive, upon exercise thereof, the excess of (1) the Fair Market Value of one Share on the
date of exercise over (2) the SAR Exercise Price. The Award Agreement for a SAR (except those that constitute Substitute Awards) shall specify the SAR Exercise Price, which shall be fixed on the Grant Date as not less than the Fair Market Value
of a Share on that date. SARs may be granted alone or in conjunction with all or part of an Option or at any subsequent time during the term of such Option or in conjunction with all or part of any other Award. A SAR granted in tandem with an
outstanding Option after the Grant Date of such Option shall have a SAR Exercise Price that is equal to the Option Price; provided, however, that the SAR Exercise Price may not be less than the Fair Market Value of a Share on the Grant
Date of the SAR to the extent required by Section 409A. 
  

	 	9.2.	 Other Terms 

The Board shall determine at the Grant Date the time or times at which and the circumstances under which a SAR may be exercised in whole or in
part (including based on achievement of performance goals and/or future service requirements), the time or times at which SARs shall cease to be or become exercisable after Separation from Service or upon other terms, the method of exercise, whether
or not a SAR shall be in tandem or in combination with any other Award, and any other terms of any SAR. 
  

	 	9.3.	 Term of SARs 

The term of a SAR granted under the Plan shall be determined by the Board; provided, however, that such term shall not exceed 10
years. 

  
 11 

	 	9.4.	 Payment of SAR Amount 

Upon exercise of a SAR, a Grantee shall be entitled to receive payment from the Company (in cash or Shares) in an amount determined by
multiplying: 
  

	 	(1)	 the difference between the Fair Market Value of a Share on the date of exercise over the SAR Exercise Price; by

  

	 	(2)	 the number of Shares with respect to which the SAR is exercised. 

 

	10.	 TERMS OF RESTRICTED SHARES AND RESTRICTED STOCK UNITS (RSUs) 

 

	 	10.1.	 Restrictions 

At the time of grant, the Board may establish a period of time (a “Restricted Period”) and any additional restrictions
including the satisfaction of corporate or individual performance objectives applicable to an Award of Restricted Shares or RSUs in accordance with Section 12. Each Award of Restricted Shares or RSUs may be subject to a
different Restricted Period and additional restrictions. Neither Restricted Shares nor RSUs may be sold, transferred, assigned, pledged, or otherwise encumbered or disposed of during the Restricted Period or before the satisfaction of any other
applicable restrictions. 
  

	 	10.2.	 Restricted Share Certificates 

The Company shall issue, in the name of each Grantee to whom Restricted Shares have been granted, stock certificates or other evidence of
ownership representing the total number of Restricted Shares granted to the Grantee, as soon as reasonably practicable after the Grant Date. 
  

	 	10.3.	 Rights of Holders of Restricted Shares 

Unless the Board otherwise provides in an Award Agreement and subject to Section 17.11, holders of Restricted Shares
shall have rights as Stockholders, including voting and dividend rights. 
  

	 	10.4.	 Rights of Holders of RSUs 

 

	 	10.4.1.	 Settlement of RSUs 

RSUs may be settled in cash or Shares, as determined by the Board and set forth in the Award Agreement. The Award Agreement
shall also set forth whether the RSUs shall be settled (1) within the time period specified for “short-term deferrals” under Section 409A or (2) otherwise within the requirements of Section 409A, in which case the Award
Agreement shall specify upon which events such RSUs shall be settled. 
  

	 	10.4.2.	 Voting and Dividend Rights 

Unless otherwise stated in the applicable Award Agreement and subject to Section 17.11, holders of
RSUs shall not have rights as Stockholders, including no voting or dividend rights. 

  
 12 

	 	10.4.3.	 Creditors’ Rights 

A holder of RSUs shall have no rights other than those of a general creditor of the Company. RSUs represent an unfunded and
unsecured obligation of the Company, subject to the applicable Award Agreement. 
  

	 	10.5.	 Purchase of Restricted Shares 

The Grantee shall be required, to the extent required by applicable law, to purchase Restricted Shares from the Company at a Purchase Price
equal to the greater of (1) the aggregate par value of the Restricted Shares or (2) the Purchase Price, if any, specified in the related Award Agreement. If specified in the Award Agreement, the Purchase Price may be deemed paid by
services already rendered. The Purchase Price shall be payable in a form described in Section 11 or, if permitted by the Board, in consideration for past services rendered. 

 

	 	10.6.	 Delivery of Shares 

Upon the expiration or termination of any Restricted Period and the satisfaction of any other terms prescribed by the Board, the restrictions
applicable to Restricted Shares or RSUs settled in Shares shall lapse, and, unless otherwise provided in the Award Agreement, a stock certificate or other evidence of ownership for such Shares shall be delivered, free of all such restrictions, to
the Grantee or the Grantee’s beneficiary or estate, as the case may be. 
  

	11.	 FORM OF PAYMENT FOR OPTIONS AND RESTRICTED SHARES 

 

	 	11.1.	 General Rule 

Payment of the Option Price for an Option or the Purchase Price for Restricted Shares shall be made in cash or in cash equivalents acceptable
to the Company, except as provided in this Section 11. 
  

	 	11.2.	 Surrender of Shares 

To the extent the Award Agreement so provides, payment of the Option Price for an Option or the Purchase Price for Restricted Shares may be
made all or in part through the tender to, or withholding by, the Company of Shares that shall be valued, for purposes of determining the extent to which the Option Price or Purchase Price for Restricted Shares has been paid thereby, at their Fair
Market Value on the date of exercise or surrender. Notwithstanding the foregoing, in the case of an Incentive Stock Option, the right to make payment in the form of already owned Shares may be authorized only at the time of grant. 

 

	 	11.3.	 Cashless Exercise 

With respect to an Option only (and not with respect to Restricted Shares), to the extent permitted by law and to the extent the Award
Agreement so provides, payment of the Option Price may be made all or in part through a cashless exercise program approved by and acceptable to the Company. 
  

	 	11.4.	 Other Forms of Payment 

To the extent the Award Agreement so provides, payment of the Option Price or the Purchase Price for Restricted Shares may be made in any other
form that is consistent with applicable laws, regulations, and rules. 

  
 13 

	12.	 PERFORMANCE AWARDS 

The right of a Grantee to exercise or receive a grant or settlement of any Award, and the timing thereof, may be subject to such performance
terms as may be specified by the Board. The Board may use such business criteria and other measures of performance as it may deem appropriate in establishing any performance terms. 

 

	13.	 OTHER STOCK-BASED AWARDS 

 

	 	13.1.	 Grant of Other Stock-based Awards 

Other Stock-based Awards may be granted either alone or in addition to or in conjunction with other Awards. Other Stock-based Awards may be
granted in lieu of other cash or other compensation to which a Service Provider is entitled from the Company or may be used in the settlement of amounts payable in Shares under any other compensation plan or arrangement of the Company. Subject to
the terms of the Plan, the Board shall determine the persons to whom and the time or times at which such Awards may be made, the number of Shares to be granted under such Awards, and all other terms of such Awards. Unless the Board determines
otherwise, any such Award shall be confirmed by an Award Agreement, which shall contain such terms as the Board determines to be necessary or appropriate to carry out the intent of the Plan with respect to such Award. 

 

	 	13.2.	 Terms of Other Stock-based Awards 

Any Shares subject to Awards made under this Section 13 may not be sold, assigned, transferred, pledged, or otherwise
encumbered before the date on which the Shares are issued, or, if later, the date on which any applicable restriction, performance requirement, or deferral period lapses. 
  

	14.	 REQUIREMENTS OF LAW 

 

	 	14.1.	 General 

The Company shall not be required to sell or issue any Shares under any Award if the sale or issuance of such Shares would constitute a
violation by the Grantee, any other individual, or the Company of any law or regulation of any governmental authority, including any federal or state securities laws or regulations. If at any time the Company determines that the listing,
registration, or qualification of any Shares subject to an Award upon any securities exchange or under any governmental regulatory body is necessary or desirable as a term of, or in connection with, the issuance or purchase of Shares hereunder, no
Shares may be issued or sold to the Grantee or any other individual exercising an Option unless such listing, registration, qualification, consent or approval shall have been effected or obtained free of any terms not acceptable to the Company, and
any delay caused thereby shall in no way affect the date of termination of the Award. Specifically, in connection with the Securities Act, upon the exercise of any Option or the delivery of any Shares underlying an Award, unless a registration
statement under the Securities Act is in effect with respect to the Shares covered by such Award, the Company shall not be required to sell or issue such Shares unless the Board has received evidence satisfactory to it that the Grantee or any other
individual exercising an Option may acquire such Shares under an exemption from registration under the Securities Act. The Company may, but shall not be obligated to, register any securities covered hereby under the Securities Act. The Company shall
not be obligated to take any affirmative action in order to cause the exercise of an Option or the issuance of Shares under the Plan to comply with any law or regulation of any governmental authority. As to any jurisdiction that expressly imposes
the requirement that an Option shall not be exercisable until the Shares covered by such Option are registered or are exempt from registration, the exercise of such Option (under circumstances in which the laws of such jurisdiction apply) shall be
deemed conditioned upon the effectiveness of such registration or the availability of such an exemption. The Board may require the Grantee to sign such additional documentation, make such representations, and furnish such information as the Board
may consider appropriate in connection with the grant of Awards or issuance or delivery of Shares in compliance with applicable laws. 

  
 14 

	 	14.2.	 California Grantees 

The Plan is intended to comply with Section 25102(o) of the California Corporations Code, to the extent applicable. In that regard, to the
extent required by Section 25102(o), (1) the terms of any Options or SARs, to the extent vested and exercisable upon a Grantee’s Separation from Service, shall include any minimum exercise periods after Separation from Service specified by
Section 25102(o) and (2) any repurchase right of the Company with respect to Issued Shares shall include a minimum 90-day notice requirement. Any Plan term that is inconsistent with
Section 25102(o) shall, without further act or amendment by the Company or the Board, be reformed to comply with the requirements of Section 25102(o). 
  

	15.	 EFFECT OF CHANGES IN CAPITALIZATION 

 

	 	15.1.	 Changes in Common Stock 

If (1) the number of outstanding Shares is increased or decreased or the Shares are changed into or exchanged for a different number or
kind of shares or other securities of the Company on account of any recapitalization, reclassification, stock split, reverse split, combination of shares, exchange of shares, stock dividend or other distribution payable in capital stock, or other
increase or decrease in such Shares effected without receipt of consideration by the Company occurring after the Effective Date or (2) there occurs any spin-off,
split-up, extraordinary cash dividend, or other distribution of assets by the Company, (A) the number and kinds of shares for which grants of Awards may be made, (B) the number and kinds of shares
for which outstanding Awards may be exercised or settled, and (C) the performance goals relating to outstanding Awards, shall be equitably adjusted by the Company. In addition, in the event of any such increase or decease in the number of
outstanding shares or other transaction described in clause (2) above, the Option Price per share of outstanding Options and SAR Exercise Price per share of outstanding SARs shall be equitably adjusted. For purposes of clarity, the total number
of Shares reserved for issuance set forth in Section 4.1 (other than Shares from the Prior Plan) takes into account a 1.2 for 1 stock split effected by the Company on October 18, 2018). 

 

	 	15.2.	 Effect of Certain Transactions 

Except as otherwise provided in an Award Agreement, in the event of a Corporate Transaction, the Plan and the Awards shall continue in effect
in accordance with their respective terms, except that after a Corporate Transaction either (1) each outstanding Award shall be treated as provided for in the agreement entered into in connection with the Corporate Transaction or (2) if
not so provided in such agreement, each Grantee shall be entitled to receive in respect of each Share subject to any outstanding Awards, upon exercise or payment or transfer in respect of any Award, the same number and kind of stock, securities,
cash, property, or other consideration that each Stockholder was entitled to receive in the Corporate Transaction in respect of one Share; provided, however, that, unless otherwise determined by the Board, such stock, securities, cash,
property or other consideration shall remain subject to all of the terms (including performance criteria) that were applicable to the Awards before such Corporate Transaction. Without limiting the generality of the foregoing, the treatment of
outstanding Options and SARs under this Section 15.2 in connection with a Corporate Transaction in which the consideration paid or distributed to the Stockholders is not entirely shares of common stock of the acquiring or
resulting corporation may include the cancellation of outstanding Options and SARs upon consummation of the Corporate Transaction as long as, at the election of the Board, (A) the holders of affected Options and SARs have been given a period of
at least 15 days before the date of the consummation of the Corporate Transaction to exercise the Options or SARs (to the extent otherwise exercisable) or (B) the holders of the affected Options and SARs are paid (in cash or cash equivalents)
in respect of each Share covered by the Option or SAR being canceled an amount equal to the excess, if any, of the per Share price paid or distributed to Stockholders in the 

  
 15 

 
Corporate Transaction (the value of any noncash consideration to be determined by the Board) over the Option Price or SAR Exercise Price, as applicable. For avoidance of doubt, (i) the
cancellation of Options and SARs under clause (B) of the preceding sentence may be effected notwithstanding any other term of the Plan or any Award Agreement and (ii) if the amount determined under clause (B) of the preceding sentence
is zero or less, the affected Option or SAR may be cancelled without any payment therefore. The treatment of any Award as provided in this Section 15.2 shall be conclusively presumed to be appropriate for purposes of
Section 15.1. 
  

	 	15.3.	 Change in Control 

For any Awards outstanding as of the date of a Change in Control, either of the following provisions shall apply, depending on whether, and the
extent to which, Awards are assumed, converted, or replaced by the resulting entity in a Change in Control, unless otherwise provided by the Award Agreement: 
  

	 	(1)	 To the extent such Awards are not assumed, converted, or replaced by the resulting entity in the Change in
Control, then upon the Change in Control such outstanding Awards that may be exercised shall become fully exercisable, all restrictions with respect to such outstanding Awards, other than for Performance Awards, shall lapse and become vested and
nonforfeitable, and for any outstanding Performance Awards the target payout opportunities attainable under such Awards shall be deemed to have been fully earned as of the Change in Control based upon the greater of (A) an assumed achievement
of all relevant performance goals at the “target” level or (B) the actual level of achievement of all relevant performance goals against target as of the Company’s fiscal quarter end preceding the Change in Control.

  

	 	(2)	 To the extent such Awards are assumed, converted, or replaced by the resulting entity in the Change in Control,
if, within 24 months after the date of the Change in Control, the Service Provider has a Separation from Service by the Company other than for Cause (which may include a Separation from Service by the Service Provider for “good reason” if
provided in the applicable Award Agreement), then such outstanding Awards that may be exercised shall become fully exercisable, all restrictions with respect to such outstanding Awards, other than for Performance Awards, shall lapse and become
vested and nonforfeitable, and for any outstanding Performance Awards the target payout opportunities attainable under such Awards shall be deemed to have been fully earned as of the Separation from Service based upon the greater of: (A) an
assumed achievement of all relevant performance goals at the “target” level, or (B) the actual level of achievement of all relevant performance goals against target as of the Company’s fiscal quarter end preceding the Change in
Control. 

  

	 	15.4.	 Adjustments 

Adjustments under this Section 15 related to Shares or other securities of the Company shall be made by the Board. No
fractional Shares or other securities shall be issued under any such adjustment, and any fractions resulting from any such adjustment shall be eliminated in each case by rounding downward to the nearest whole Share. 

 

	16.	 NO LIMITATIONS ON COMPANY 

The grant of Awards shall not affect or limit in any way the right or power of the Company to make adjustments, reclassifications,
reorganizations, or changes of its capital or business structure or to merge, consolidate, dissolve, or liquidate, or to sell or transfer all or any part of its business or assets. 

  
 16 

	17.	 TERMS APPLICABLE GENERALLY TO AWARDS 

 

	 	17.1.	 Disclaimer of Rights 

No term of the Plan or any Award Agreement shall be construed to confer upon any individual the right to remain in the employ or service of the
Company or any Affiliate, or to interfere in any way with any contractual or other right or authority of the Company either to increase or decrease the compensation or other payments to any individual at any time, or to terminate any employment or
other relationship between any individual and the Company. In addition, notwithstanding any other term of the Plan, unless otherwise stated in the applicable Award Agreement, no Award shall be affected by any change of duties or position of the
Grantee, so long as such Grantee continues to be a Service Provider. The obligation of the Company to pay any benefits under the Plan shall be interpreted as a contractual obligation to pay only those amounts described herein, in the manner and
under the terms prescribed herein. The Plan shall in no way be interpreted to require the Company to transfer any amounts to a third party trustee or otherwise hold any amounts in trust or escrow for payment to any Grantee or beneficiary under the
Plan. 
  

	 	17.2.	 Nonexclusivity of the Plan 

Neither the adoption of the Plan nor the submission of the Plan to the Stockholders for approval shall be construed as creating any limitations
upon the right and authority of the Board to adopt such other incentive compensation arrangements (which arrangements may be applicable either generally to a class or classes of individuals or specifically to a particular individual or particular
individuals), including the granting of Options as the Board determines desirable. 
  

	 	17.3.	 Withholding Taxes 

The Company or an Affiliate, as the case may be, shall have the right to deduct from payments of any kind otherwise due to a Grantee any
federal, state, or local taxes of any kind required by law to be withheld (1) with respect to the vesting of or other lapse of restrictions applicable to an Award, (2) upon the issuance of any Shares upon the exercise of an Option or SAR,
or (3) otherwise due in connection with an Award. At the time of such vesting, lapse, or exercise, the Grantee shall pay to the Company or the Affiliate, as the case may be, any amount that the Company or the Affiliate may reasonably determine
to be necessary to satisfy such withholding obligation. The Company or the Affiliate, as the case may be, may require or permit the Grantee to satisfy such obligations, in whole or in part, (A) by causing the Company or the Affiliate to
withhold up to the maximum required number of Shares otherwise issuable to the Grantee as may be necessary to satisfy such withholding obligation or (B) by delivering to the Company or the Affiliate Shares already owned by the Grantee. The
Shares so delivered or withheld shall have an aggregate Fair Market Value equal to such withholding obligations. The Fair Market Value of the Shares used to satisfy such withholding obligation shall be determined by the Company or the Affiliate as
of the date that the amount of tax to be withheld is to be determined. To the extent applicable, a Grantee may satisfy his or her withholding obligation only with Shares that are not subject to any repurchase, forfeiture, unfulfilled vesting, or
other similar requirements. 
  

	 	17.4.	 Market Standoff Requirement 

Except as otherwise provided by the Board, in connection with any IPO and upon request of the Company or the underwriters managing the IPO,
(1) no Grantee may sell, make any short sale of, loan, grant any option for the purchase of, or otherwise directly or indirectly dispose of any Issued Shares (other than Shares included in the IPO) without the prior written consent of the
Company or the underwriters, as the case may be, for such period of time from the effective date of the registration statement for the IPO as may be requested by the Company or the underwriters and (2) each Grantee shall execute an agreement
reflecting the foregoing as may be requested by the Company or the underwriters. 

  
 17 

	 	17.5.	 Other Terms; Employment Agreements 

Each Award Agreement may contain such other terms not inconsistent with the Plan as may be determined by the Board. In the event of any
conflict between the terms of an employment agreement and the Plan, the terms of the employment agreement shall govern. 
  

	 	17.6.	 Severability 

If any term of the Plan or any Award Agreement is determined to be illegal or unenforceable by any court of law in any jurisdiction, the
remaining terms hereof and thereof shall be severable and enforceable, and all terms shall remain enforceable in any other jurisdiction. 
  

	 	17.7.	 Governing Law 

The Plan and all Award Agreements shall be construed in accordance with and governed by the laws of the State of Delaware without regard to the
principles of conflicts of law that could cause the application of the laws of any jurisdiction other than the State of Delaware. For purposes of resolving any dispute that arises under the Plan, each Grantee, by virtue of receiving an Award, shall
be deemed to have submitted to and consented to the exclusive jurisdiction of the State of California and to have agreed that any related litigation shall be conducted solely in the courts of Orange County, California or the federal courts for the
U.S. for the Central District of California, where the Plan is made and to be performed, and no other courts. The Plan is not intended to be subject to the Employee Retirement Income Security Act of 1974. 

 

	 	17.8.	 Section 409A 

The Plan is intended to comply with Section 409A to the extent subject thereto, and, accordingly, to the maximum extent permitted, the
Plan shall be interpreted and administered to be in compliance therewith. Any payments described in the Plan that are due within the “short-term deferral period” as defined in Section 409A shall not be treated as deferred compensation
unless applicable laws require otherwise. For purposes of Section 409A, each installment payment under the Plan shall be treated as a separate payment. Notwithstanding any other term of the Plan, to the extent required to avoid accelerated
taxation or tax penalties under Section 409A, amounts that would otherwise be payable and benefits that would otherwise be provided under the Plan during the six-month period immediately after the
Grantee’s Separation from Service shall instead be paid on the first payroll date after the six-month anniversary of the Grantee’s Separation from Service (or the Grantee’s death, if earlier).
Notwithstanding the foregoing, neither the Company nor the Board shall have any obligation to take any action to prevent the assessment of any additional tax or penalty on any Grantee under Section 409A and neither the Company nor the Board
shall have any liability to any Grantee for such tax or penalty. 
  

	 	17.9.	 Separation from Service 

The Board shall determine the effect of a Separation from Service upon Awards, and such effect shall be set forth in the appropriate Award
Agreement. Without limiting the foregoing, the Board may provide in the Award Agreements at the time of grant, or any time thereafter with the consent of the Grantee, the actions that may be taken upon the occurrence of a Separation from Service,
including accelerated vesting or termination, depending upon the circumstances surrounding the Separation from Service. 

  
 18 

	 	17.10.  	 Transferability of Awards and Issued Shares 

 

	 	  17.10.1.	   Transfers in General 

Unless otherwise authorized in the applicable Award Agreement, no Award shall be assignable or transferable by the Grantee to
whom it is granted, other than by will or the laws of descent and distribution, and, during the lifetime of the Grantee, only the Grantee personally (or the Grantee’s personal representative) may exercise rights under the Plan. Upon the death
of the Grantee, any Issued Shares then held by the Grantee and any Issued Shares acquired thereafter by the Grantee’s legal representative shall be subject to the terms of the Plan, and the Grantee’s estate, executors, administrators,
personal representatives, heirs, legatees, and distributees shall be obligated to convey such Issued Shares to the Company or its assigns under the terms of the Plan. 
  

	 	  17.10.2.  	 Issued Shares 

Before an IPO, no Issued Shares may be sold, assigned, transferred, pledged, hypothecated, given away, or in any other manner
disposed of or encumbered, whether voluntarily or by operation of law, unless (A) such action is specifically permitted by and in compliance with the terms of the applicable Award Agreement, all applicable securities laws, and the Plan;
(B) such action does not cause the Company to become subject to the reporting requirements of the Exchange Act; and (C) all beneficiaries of the Issued Shares consent in writing to be bound by the Plan. The Company may require that a
legend be placed on any certificate representing the Issued Shares that describes the restrictions under this Section 17.10.2. In connection with any proposed action under this Section 17.10.2, the
Board may require the Grantee to provide at the Grantee’s own expense an opinion of counsel, satisfactory to the Board, that the action is in compliance with all applicable laws. Any attempted sale, assignment, transfer, pledge, hypothecation,
gift, or other disposition or encumbrance of Issued Shares not in accordance with this Section 17.10.2 shall be null and void, and the Company shall not reflect in its records any change in record ownership of any Issued
Shares as a result of any such action, shall otherwise refuse to recognize any such action, and shall not in any way give effect to any such action. 
  

	 	17.11.	   Dividend Equivalent Rights 

If specified in the Award Agreement, the recipient of an Award may be entitled to receive dividend equivalent rights with respect to the Shares
or other securities covered by an Award. The terms of a dividend equivalent right may be set forth in the Award Agreement. Dividend equivalents credited to a Grantee may be paid in cash or deemed to be reinvested in additional Shares or other
securities of the Company at a price per unit equal to the Fair Market Value of a Share on the date that such dividend was paid to Stockholders. Notwithstanding the foregoing, dividends or dividend equivalents shall not be paid on any Award or
portion thereof that is unvested or on any Award that is subject to the achievement of performance criteria before the Award has become earned and payable, and dividends on restricted shares shall be subject to the same restrictions as the
restrictions to which their underlying shares are subject. 
  

	 	17.12.	   Data Protection 

A Grantee’s acceptance of an Award shall be deemed to constitute the Grantee’s acknowledgement of and consent to the collection and
processing of personal data relating to the Grantee so that the Company can meet its obligations and exercise its rights under the Plan and generally administer and manage the Plan. This data shall include data about participation in the Plan and
Shares offered or received, purchased, or sold under the Plan and other appropriate financial and other data (such as the date on which the Awards were granted) about the Grantee and the Grantee’s participation in the Plan. 

  
 19 

	 	17.13.	   Plan Construction 

In the Plan, unless otherwise stated, the following uses apply: 
  

	 	(1)	 references to a statute or law refer to the statute or law and any amendments and any successor statutes or
laws, and to all valid and binding governmental regulations, court decisions, and other regulatory and judicial authority issued or rendered thereunder, as amended, or their successors, as in effect at the relevant time; 

 

	 	(2)	 in computing periods from a specified date to a later specified date, the words “from” and
“commencing on” (and the like) mean “from and including,” and the words “to,” “until” and “ending on” (and the like) mean “to and including”; 

 

	 	(3)	 indications of time of day shall be based upon the time applicable to the location of the principal
headquarters of the Company; 

  

	 	(4)	 the words “include,” “includes,” and “including” (and the like) mean
“include, without limitation,” “includes, without limitation,” and “including, without limitation” (and the like), respectively; 

 

	 	(5)	 all references to sections are to sections in the Plan; 

 

	 	(6)	 all words used shall be construed to be of such gender or number as the circumstances and context require;

  

	 	(7)	 the captions and headings of sections have been inserted solely for convenience of reference and shall not be
considered a part of the Plan, nor shall any of them affect the meaning or interpretation of the Plan; 

  

	 	(8)	 any reference to an agreement, plan, policy, form, document or set of documents, and the rights and obligations
of the parties under any such agreement, plan, policy, form, document or set of documents, shall mean such agreement, plan, policy, form, document or set of documents as amended from time to time, and any and all modifications, extensions, renewals,
substitutions or replacements thereof; and 

  

	 	(9)	 all accounting terms not specifically defined shall be construed in accordance with GAAP.

  
 20

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00288-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00288-of-00352.parquet"}]]